18

Mar

2021

16:00

GMT

Webinar

A Peek into the Future – Repair and Replacement of the Mitral and Tricuspid Valves with the Edwards Portfolio

  • Views:

    Views Icon 14439
  • Likes:

    Heart Icon 17

Overview


This webinar, at 5pm CET / 4pm GMT, will bring together an internationally-respected faculty to review the PASCAL platform focusing on the recently CE mark approved PASCAL Ace implant system for the treatment of mitral and tricuspid regurgitation.

Through a combination of case presentations, discussion, and a live case procedure from Heidelberg University Hospital, the theory- and practical-based agenda has been formulated to best support everyday practice and enhance patient outcomes.

Pipeline products for tricuspid transcatheter replacement from Edwards Lifesciences will be shown and briefly discussed.

Performed By:

Nicolas M Van Mieghem

Nicolas M Van Mieghem

Peter Lüdike

Peter Lüdike

Philipp Lurz

Philipp Lurz

Ralph Stephan von Bardeleben

Ralph Stephan von Bardeleben

Philip Raake

Philip Raake

Faculty Biographies

Nicolas M Van Mieghem

Nicolas M Van Mieghem

Dr Nicolas M Van Mieghem obtained his medical degree and cardiology degree at the Catholic University of Leuven, Belgium. After subsequent fellowships in interventional cardiology in Ziekenhuis Oost-Limburg Genk, Belgium, Lenox Hill Hospital, New York, US and Erasmus Medical Center, Rotterdam, the Netherlands, he joined the department of interventional cardiology at the Thoraxcenter, Erasmus Medical Center, as a senior staff member in February 2010. 

He is involved in the percutaneous coronary interventions and structural heart program. He obtained the degree of PhD based upon his research in transcatheter valve therapies. So far he has published and co-authored approximately 130 scientific papers in peer-reviewed journals. 

Dr Van Mieghem is principle investigator and steering committee member in multiple ongoing international trials evaluating various coronary and transcatheter valve technologies. He is a Fellow of the European Society of Cardiology and is currently Medical Director of the department of Interventional cardiology at the Thoraxcenter.

View full profile
Peter Lüdike

Peter Lüdike

Prof Peter Lüdike is Senior Physician of the Heart Failure and Intensive Care section in the Department of Cardiology and Vascular Medicine at the West German Heart and Vascular Center, University Hospital Essen. He achieved Venia legendi for internal medicine in 2018 and was appointed as Full Professor for heart failure in 2020. His research interests include intensive care medicine, emergency medicine, heart failure, mitral valve disease and the role of macrophage migration inhibitory factor in the development of ischaemic heart disease.

View full profile
Philipp Lurz

Philipp Lurz

Prof Philipp Lurz is Deputy Head of the Department at Heart Center Leipzig, Germany, a position he has held since 2018. Previously, Prof Lurz was a Clinical Research Fellow at Great Ormond Street Hospital for Children NHS Foundation Trust. He completed his education at the University of Leipzig, and is a member of the German Society of Cardiology. Prof Luz is widely published in leading international peer-reviewed journals.

View full profile
Ralph Stephan von Bardeleben

Ralph Stephan von Bardeleben

Dr Ralph Stephan von Bardeleben is the Head of the Center of Structural Heart Disease Interventions and the Heart Valve Center in Mainz, Germany. Following the completion of his medical education at the University of Mainz and the University of California in San Francisco, US, Dr Bardeleben trained as both an imager and interventional cardiologist. Since 2004 he has served as Head of the CV imaging department. A regular speaker at international events, Dr Bardeleben's department has played key roles in a number of early 'in-man' implantations and other international trials.

View full profile
Philip Raake

Philip Raake

Prof Philip Raake is a senior physician who leads the HFU centre at the Department of Cardiology at Heidelberg University Hospital. He also runs the Interventional HF programme.

Prof Philip Raake attended medical school at the Ludwig-Maximilians University in Munich. Between 2006 and 2008, Prof Raake worked at the Center for Translational Medicine, under the direction of Prof Walter Koch, at the Thomas Jefferson University, Philadelphia.

In 2008 Prof Raake returned to Germany, where his established the first university Advanced Heart Failure Unit in Germany focusing on optimised care in advanced HF. He has authored or co-authored several papers in leading peer-reviewed journals on HF basic molecular mechanisms, and clinical aspects of advanced HF. He serves on several working groups for the German Society for Cardiology and the German Federal Physicians Association.

View full profile

SGLT-2 Inhibitors in Heart Failure: Putting the Evidence Into Practice

Published: 27 August 2021

  • Views:

    Views Icon 6406
  • Likes:

    Heart Icon 7

Overview

Full programme

  • Views:

    Views Icon 6406
  • Likes:

    Heart Icon 7
Part

of

Overview

More from this programme

Coronary Bifurcations PCI

Published: 11 June 2021

  • Views:

    Views Icon 609
  • Likes:

    Heart Icon 7

Overview

Full programme

  • Views:

    Views Icon 609
  • Likes:

    Heart Icon 7
Part

of

Overview

More from this programme

EuroPCR 2021 Wrap-up: Mitral and Tricuspid Therapies

Published: 20 May 2021

  • Views:

    Views Icon 10796
  • Likes:

    Heart Icon 7

Overview

Full programme

  • Views:

    Views Icon 10796
  • Likes:

    Heart Icon 7
Part

of

Overview

More from this programme

Optimising Treatment of HF

Published: 21 April 2021

  • Views:

    Views Icon 17954
  • Likes:

    Heart Icon 7

Overview

Full programme

  • Views:

    Views Icon 17954
  • Likes:

    Heart Icon 7
Part

of

Overview

More from this programme

Video

TCT Connect 2020 Discussion: The FORECAST Trial

Published: 21 Oct 2020

  • Views:

    Views Icon 190
  • Likes:

    Heart Icon 0

Dr Mirvat Alasnag (The King Fahd Armed Forces Hospital, Jeddah, KSA) and Prof Nick Curzen (University Hospital Southampton NHS Trust, Southampton, UK) discuss the design, outcomes, economic implications of the FORECAST late-breaking trial. 

Recorded remotely from Jeddah and Southampton, 2020. 

Recording Editors: Natascha Wienand, Tom Green
Editor: Mirjam Boros

Subscribe to